Torrent Pharmaceuticals Receives ESG Ratings from Crisil ESG Ratings and Analytics

Torrent Pharmaceuticals Receives ESG Ratings from Crisil ESG Ratings and Analytics​

Torrent Pharmaceuticals Limited has received independent environmental, social, and governance (ESG) ratings from Crisil ESG Ratings and Analytics Limited.

The ratings were assigned to evaluate the company's ESG performance. Under the assessment, the company secured a rating of 'Crisil ESG 66' and a Core ESG rating of 'Crisil Core ESG 74'.

The evaluation was conducted independently by Crisil ESG Ratings, which is a SEBI registered ESG Rating Provider.

TORNTPHARM Stock Price Movement​

Torrent Pharmaceuticals Limited shares tumbled 4.82% on Friday to settle at ₹4,763.00. The stock saw a significant sell-off during the session, with 1.40 million shares changing hands.

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.